FDA approves biosimilar to J&J?s Remicade for multiple diseases
 

FDA approves biosimilar to J&J?s Remicade for multiple diseases
(Reuters) - The U.S. Food and Drug Administration on Tuesday approved Inflectra, a cheaper version of Johnson & Johnson's drug Remicade, to treat Crohn's disease, ulcerative colitis, rheumatoid arthritis, psoriasis and arthritis of the spine.


http://rc.feedsportal.com/r/24739695...19/rc/1/rc.img

http://rc.feedsportal.com/r/24739695...19/rc/2/rc.img

http://rc.feedsportal.com/r/24739695...19/rc/3/rc.img

http://da.feedsportal.com/r/24739695...2/sc/19/a2.img
http://adchoice.feedsportal.com/r/24.../sc/19/ach.imghttp://pi.feedsportal.com/r/24739695.../sc/19/a2t.imghttp://pi2.feedsportal.com/r/2473969...sc/19/a2t2.imghttp://i1.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...18:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...18:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/lYxWja1js04